Literature DB >> 15735482

Infected and noninfected ascites in pediatric patients.

Sandra M G Vieira1, Ursula Matte, Carlos O Kieling, Afonso L Barth, Cristina T Ferreira, Aline F Souza, Adriano Taniguchi, Themis R da Silveira.   

Abstract

OBJECTIVES: To determine the prevalence of spontaneous bacterial peritonitis, ascites with bacterial infection and noninfected ascites in pediatric patients with portal hypertensive ascites and to compare the clinical and laboratory features of infected and noninfected ascites.
METHODS: Forty-one episodes of portal hypertensive ascites (serum-ascites albumin gradient >1.1 g/dL) in 31 patients were studied. Median age was 2.9 years. Twenty-four (77.4%) patients were cirrhotic and 20 (83.3%) were classified as Child-Pugh C. Median pediatric end-stage liver disease score was 18.5. The following ascites features were assessed: polymorphonuclear neutrophil cell count, cytology, pH, concentration of glucose, lactic dehydrogenase, total protein and albumin, Gram stain and bacteriological culture. Blood was sampled for complete blood count, coagulation studies, liver and renal function tests. Groups were compared by Mann-Whitney and chi tests (P < 0.05).
RESULTS: Noninfected ascites were observed in 29 of 41 samples, spontaneous bacterial peritonitis in eight of 41 and ascites with bacterial infection in four of 41. The most prevalent clinical features were fever, voluminous ascites and encephalopathy, but there were no significant differences in the clinical features of the groups. All patients with infected ascites were cirrhotic. There was no statistical difference in Child-Pugh or pediatric end-stage liver disease status between patients with infected and noninfected ascites. Culture of ascetic fluid was positive in four of eight cases of spontaneous bacterial peritonitis. Gram-negative rods were the most prevalent bacteria cultured. Except for serum albumin, no statistical differences in biochemical markers were observed between patients with infected and noninfected ascites.
CONCLUSIONS: The prevalence of infected ascites was 29.2%. With the exception of serum albumin, there were no differences in the clinical and biochemical features of patients with infected ascites and noninfected ascites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735482     DOI: 10.1097/01.mpg.0000154659.54735.1d

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

Review 1.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

2.  Organisms causing spontaneous bacterial peritonitis in children with liver disease and ascites in Southern Iran.

Authors:  Mahmood Haghighat; Seyed Mohsen Dehghani; Abdolvahab Alborzi; Mohammad Hadi Imanieh; Bahman Pourabbas; Mehdi Kalani
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

Review 3.  Ascites in childhood liver disease.

Authors:  Surender Kumar Yachha; Vikrant Khanna
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

Review 4.  Advances in management of end stage liver disease in children.

Authors:  Aradhana Aneja; Elizabeth Scott; Rohit Kohli
Journal:  Med J Armed Forces India       Date:  2021-03-25

5.  Diagnosis of spontaneous bacterial peritonitis in infants and children with chronic liver disease: A cohort study.

Authors:  Mortada H F El-Shabrawi; Ola El-Sisi; Sawsan Okasha; Mona Isa; Sayed Abou Elmakarem; Iman Eyada; Zainab Abdel-Latif; Gamal El-Batran; Naglaa Kamal
Journal:  Ital J Pediatr       Date:  2011-05-21       Impact factor: 2.638

6.  Serum C-Reactive Protein in Children with Liver Disease and Ascites.

Authors:  Gholamreza Kalvandi; Naser Honar; Bita Geramizadeh; Maryam Ataollahi; Asghar Rahmani; Hazhir Javaherizadeh
Journal:  Hepat Mon       Date:  2016-07-23       Impact factor: 0.660

7.  Routine analysis of ascitic fluid for evidence of infection in children with chronic liver disease: Is it mandatory?

Authors:  Carolyne Ghobrial; Engy Adel Mogahed; Hanaa El-Karaksy
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.